MEDINET Co., Ltd. (2370.T)
JPY 37.0
(0.0%)
JPY 37.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.43 Billion JPY | -14.66% |
| 2022 | -1.25 Billion JPY | -48.7% |
| 2021 | -843.39 Million JPY | -0.16% |
| 2020 | -842.01 Million JPY | -5.87% |
| 2019 | -795.3 Million JPY | 73.91% |
| 2018 | -3.04 Billion JPY | -17.09% |
| 2017 | -2.6 Billion JPY | -58.45% |
| 2016 | -1.64 Billion JPY | 4.04% |
| 2015 | -1.71 Billion JPY | -8.33% |
| 2014 | -1.58 Billion JPY | -353.68% |
| 2013 | -348.41 Million JPY | 44.25% |
| 2012 | -624.98 Million JPY | -15.2% |
| 2011 | -542.52 Million JPY | -223.71% |
| 2010 | 438.55 Million JPY | 78.37% |
| 2009 | 245.87 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -317.18 Million JPY | 7.15% |
| 2024 Q2 | -341.59 Million JPY | -16.73% |
| 2024 Q1 | -292.63 Million JPY | 25.52% |
| 2023 Q4 | -392.89 Million JPY | -6.63% |
| 2023 FY | -1.43 Billion JPY | -14.66% |
| 2023 Q2 | -351.05 Million JPY | -7.84% |
| 2023 Q3 | -368.48 Million JPY | -4.96% |
| 2023 Q1 | -325.52 Million JPY | -22.68% |
| 2022 FY | -1.25 Billion JPY | -48.7% |
| 2022 Q4 | -265.34 Million JPY | 14.35% |
| 2022 Q2 | -336.78 Million JPY | 1.57% |
| 2022 Q1 | -342.14 Million JPY | -16.13% |
| 2022 Q3 | -309.81 Million JPY | 8.01% |
| 2021 Q3 | -39.08 Million JPY | 80.53% |
| 2021 Q1 | -308.93 Million JPY | -48.11% |
| 2021 Q2 | -200.75 Million JPY | 35.02% |
| 2021 Q4 | -294.61 Million JPY | -653.76% |
| 2021 FY | -843.39 Million JPY | -0.16% |
| 2020 FY | -842.01 Million JPY | -5.87% |
| 2020 Q4 | -208.58 Million JPY | 22.9% |
| 2020 Q1 | -167.19 Million JPY | -1449.44% |
| 2020 Q2 | -195.71 Million JPY | -17.06% |
| 2020 Q3 | -270.52 Million JPY | -38.22% |
| 2019 Q1 | -222.85 Million JPY | 48.98% |
| 2019 Q3 | -308.52 Million JPY | -11.65% |
| 2019 Q4 | 12.39 Million JPY | 104.02% |
| 2019 FY | -795.3 Million JPY | 73.91% |
| 2019 Q2 | -276.31 Million JPY | -23.99% |
| 2018 Q2 | -978.87 Million JPY | 13.06% |
| 2018 Q3 | -507 Million JPY | 48.2% |
| 2018 FY | -3.04 Billion JPY | -17.09% |
| 2018 Q1 | -1.12 Billion JPY | 5.06% |
| 2018 Q4 | -436.78 Million JPY | 13.85% |
| 2017 Q1 | -307.3 Million JPY | 44.84% |
| 2017 FY | -2.6 Billion JPY | -58.45% |
| 2017 Q2 | -684.42 Million JPY | -122.72% |
| 2017 Q4 | -1.18 Billion JPY | -178.33% |
| 2017 Q3 | -426.07 Million JPY | 37.75% |
| 2016 Q4 | -557.1 Million JPY | -88.9% |
| 2016 Q1 | -370.44 Million JPY | 38.85% |
| 2016 Q2 | -420.73 Million JPY | -13.57% |
| 2016 Q3 | -294.91 Million JPY | 29.9% |
| 2016 FY | -1.64 Billion JPY | 4.04% |
| 2015 FY | -1.71 Billion JPY | -8.33% |
| 2015 Q2 | -341.57 Million JPY | -15.13% |
| 2015 Q4 | -605.82 Million JPY | -29.38% |
| 2015 Q3 | -468.24 Million JPY | -37.09% |
| 2015 Q1 | -296.68 Million JPY | 68.6% |
| 2014 Q2 | 53.5 Million JPY | 118.91% |
| 2014 FY | -1.58 Billion JPY | -353.68% |
| 2014 Q4 | -944.79 Million JPY | -132.38% |
| 2014 Q3 | -406.57 Million JPY | -859.94% |
| 2014 Q1 | -282.85 Million JPY | -24.73% |
| 2013 Q2 | 254.18 Million JPY | 279.98% |
| 2013 Q3 | -234.59 Million JPY | -192.29% |
| 2013 Q4 | -226.78 Million JPY | 3.33% |
| 2013 FY | -348.41 Million JPY | 44.25% |
| 2013 Q1 | -141.23 Million JPY | 18.6% |
| 2012 Q3 | -115.55 Million JPY | 32.19% |
| 2012 Q1 | -165.5 Million JPY | -6.17% |
| 2012 FY | -624.98 Million JPY | -15.2% |
| 2012 Q2 | -170.41 Million JPY | -2.97% |
| 2012 Q4 | -173.5 Million JPY | -50.14% |
| 2011 FY | -542.52 Million JPY | -223.71% |
| 2011 Q3 | -285.15 Million JPY | -165.6% |
| 2011 Q2 | -107.36 Million JPY | -1926.23% |
| 2011 Q4 | -155.88 Million JPY | 45.33% |
| 2011 Q1 | 5.87 Million JPY | -97.01% |
| 2010 Q3 | -18.67 Million JPY | -117.58% |
| 2010 Q1 | 154.64 Million JPY | -13.39% |
| 2010 FY | 438.55 Million JPY | 78.37% |
| 2010 Q4 | 196.34 Million JPY | 1151.41% |
| 2010 Q2 | 106.24 Million JPY | -31.3% |
| 2009 Q4 | 178.54 Million JPY | 28.36% |
| 2009 Q2 | -6.8 Million JPY | 89.52% |
| 2009 FY | 245.87 Million JPY | 0.0% |
| 2009 Q1 | -64.96 Million JPY | 0.0% |
| 2009 Q3 | 139.1 Million JPY | 2143.48% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 474.466% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -172.9% |
| GNI Group Ltd. | 8.09 Billion JPY | 117.765% |
| Linical Co., Ltd. | 338.26 Million JPY | 525.094% |
| Trans Genic Inc. | 4.08 Million JPY | 35300.734% |
| Soiken Holdings Inc. | -662.2 Million JPY | -117.146% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 1140.824% |
| AnGes, Inc. | -7.43 Billion JPY | 80.666% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -11.63% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 80.009% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 870.218% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -84.352% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -24.725% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -18.937% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -76.998% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -344.275% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -17.863% |
| Kidswell Bio Corporation | -1.42 Billion JPY | -1.116% |
| PeptiDream Inc. | 3.03 Billion JPY | 147.366% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 25.822% |
| Ribomic Inc. | -1.02 Billion JPY | -40.392% |
| SanBio Company Limited | -2.64 Billion JPY | 45.615% |
| Healios K.K. | -3.82 Billion JPY | 62.387% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -23.104% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 3.468% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | -0.599% |
| StemRIM | -2.02 Billion JPY | 28.885% |
| CellSource Co., Ltd. | 923.14 Million JPY | 255.767% |
| FunPep Company Limited | -933.41 Million JPY | -54.052% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -68.348% |
| Stella Pharma Corporation | -763.74 Million JPY | -88.275% |
| TMS Co., Ltd. | -960.04 Million JPY | -49.78% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -27.251% |
| Cuorips Inc. | -632.18 Million JPY | -127.458% |
| K Pharma,Inc. | 260.33 Million JPY | 652.357% |
| Takara Bio Inc. | 1.48 Billion JPY | 197.159% |
| ReproCELL Incorporated | -31.41 Million JPY | -4477.272% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 5551.323% |
| StemCell Institute Inc. | 310.98 Million JPY | 562.392% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 1104.372% |
| CellSeed Inc. | -846.53 Million JPY | -69.863% |